Risk factors, outcomes, and epidemiology associated with Clostridium difficile infection in patients with hematologic malignancies in a tertiary care hospital in China.
Conclusion: The incidence of CDI did not differ between patients receiving chemotherapy and those receiving hematopoietic stem cell transplantation. The only risk factor for chemotherapy patients was treatment with etoposide.
PMID: 25596117 [PubMed - as supplied by publisher]
Source: Journal of Medical Microbiology - Category: Microbiology Authors: Gu SL, Chen YB, Lv T, Zhang XW, Wei ZQ, Shen P, Li LJ Tags: J Med Microbiol Source Type: research
More News: Cancer & Oncology | Chemotherapy | Clostridium Difficile | Epidemiology | Hematology | Microbiology | Stem Cell Therapy | Stem Cells | Study | Transplants